Memorial Sloan-Kettering
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform
The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.
Researchers showed that methylation patterns on cell-free DNA in the eye can differentiate retinoblastomas into more or less aggressive subtypes.
Single-Cell Sequencing Reveals Breast, Ovarian Cancer-Related Mutational Processes
Tracing structural variants and haplotype patterns in individual cells, researchers uncovered mutational processes that contribute to cancer formation, diversity, and evolution.
Five research groups participating in the NHGRI-funded Molecular Phenotypes of Null Alleles in Cells initiative aim to characterize 1,000 null alleles in a pilot phase.